Securitas

Good Q1 2025, portfolio review

08/05/25 -"Organic sales growth and operating margin improvement were in line with expectations, with all divisions contributing to the overall performance. At constant currency, sales growth in Technology and ..."

PDF page sample
Pages
45
Language
English
Published on
08/05/25
Download
You may also be interested by these reports :
04/09/25
The change in the target price reflects the update of our estimates and the effect on DCF and peer-based valuations. Despite a challenging macro ...
06/08/25
Q2 2025 results showed a return to organic growth for the Adecco GBU, and a slower decline for LHH and, to a lesser extent, Akkodis, which remains ...
31/07/25
Even though H1 operating results missed street expectations, there was a massive FCF beat. Moreover, there were important – though early stage – ...
30/07/25
Securitas beat expectations in Q2 2025, with solid organic growth, supported by North America and Europe, and a broad-based improvement in operating ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO